Physician profile
Norma J Flack
NPI 1326010166
$9,850.57
in general payments reported to CMS, 2019-2025
35 companies · $1,536 in 2025
The $1,536 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,582 · 2020: $783 · 2021: $862 · 2022: $1,398 · 2023: $1,347 · 2024: $2,341 · 2025: $1,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,088 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,087.90 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,469.89 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Allergan, INC. | $1,019.75 | 2019-2022 | |
| Alcon Vision LLC | $913.89 | 2022-2025 | Hydrus Microstent, Rocklatan, Simbrinza |
| Abbvie INC. | $777.24 | 2023-2025 | |
| Medical Device Business Services, INC. | $619.80 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $518.24 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $479.40 | 2019-2021 | |
| Innovation Technologies INC | $322.57 | 2024-2025 | Irrisept |
| Stryker Corporation | $307.43 | 2022-2025 | Cascadia Interbody System |
| Horizon Therapeutics Plc | $260.79 | 2021 | |
| Csl Behring | $248.19 | 2020-2025 | Kcentra |
| Sight Sciences, INC. | $228.60 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Mallinckrodt Hospital Products INC. | $178.89 | 2021-2025 | Acthar |
| Atricure, INC. | $165.83 | 2024 | |
| Sun Pharmaceutical Industries INC. | $161.73 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $157.93 | 2023 | Ribloc |
| Biotissue Holdings INC. | $155.16 | 2024 | |
| Davol INC. | $141.32 | 2024 | Phasix Mesh |
| Johnson & Johnson Surgical Vision, INC. | $137.14 | 2023-2024 | Tecnis Iol, Catalys System, Tecnis Iol |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 | |
| Merck Sharp & Dohme LLC | $125.00 | 2019 | |
| Baxter Healthcare | $125.00 | 2019 | |
| Acell, INC. | $125.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $122.12 | 2020 | |
| Heron Therapeutics, INC. | $121.84 | 2025 | Aponvie, Zynrelef |
| Dompe US, INC. | $119.81 | 2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $110.68 | 2019 | |
| Medline Industries LP | $99.82 | 2019 | |
| Optos, INC. | $98.92 | 2020 | |
| Kci USA, INC. | $98.61 | 2022 | |
| Glaukos Corporation | $85.80 | 2019-2023 | |
| New World Medical,INC. | $72.68 | 2022 | |
| Optovue, INC. | $65.51 | 2019 | |
| Shire North American Group INC | $49.68 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Flack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.